Dvs > 2 millioner doser Cysview årlig.
Hvis vi antar en fortjeneste på 5000kr pr dose blir det en årlig inntekt på 10 mrd.
Hvis vi så antar en PE på 10-20 får vi .......en ganske bra pris på Photocure :-)

Spørsmålet er, tror vi BLCC blir Standard of Care ?

"One of the greatest problems with the clinical management of non-muscle invasive bladder cancer is the very high recurrence rate (31-78% at 5 years)6. Consequently,
it is necessary to maintain patients on lifelong surveillance, which includes periodic cystoscopic evaluations along with urinary cytology assessments as well as periodic CT imaging to assess the urothelium of the upper urinary tracts. It is estimated that
over 4 million cystoscopies are performed each year and that approximately $4
billion per year is spent on bladder cancer surveillance, making bladder cancer the most expensive cancer over the lifetime of a patient7, with ~60% of the costs attributable to treatment of recurrences8."

http://www.crt.org/images/files/file/Scherr-Advancements-in-Urological-Oncology.pdf